• Skip to primary navigation
  • Skip to main content

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
      • SAGES Robotics Residents and Fellows Courses
      • MIS Fellows Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search the SAGES Site
    • Guidelines Search
    • Video Search
    • Search Images
    • Search Abstracts
  • OWLS/FLS
  • Login
You are here: Home / Abstracts / Clinical Prognoses After Laparoscopic Assisted Gastrectomy for 76 Cases with Earlyl Gastric Cancer

Clinical Prognoses After Laparoscopic Assisted Gastrectomy for 76 Cases with Earlyl Gastric Cancer

(1) objective of this study Although Laparoscopic assisted gastrectomy (LAG) is has been accepted procedure for early stages of gastric cancer, the morbidity and modality are not clear compared to open gastrectomy (OG). We show our patientsf prognoses after LAG. This is a retrospective and single facility report.
(2) methods and procedures We have performed 76 LAG and 94 OG cases of clinical StageIA and IB early gastric cancer from January 1999 through December 2005. Follow-up terms were from 2years and 8maonthes through 5 years. Total gastrectomy were not included. The exclusion criteria specified cancer suitable for Endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD).
(3) results No statistical significances between LAG and OG patients about their backgrounds (age, gender), major morbidity and mortality. The details were 51 male, 25 female for LAG, and 68 male, 26 female for OG. The mean ages were 55.6 years of LAG and 58.7 years of OG. In LAG group, three cases were converted to open surgery. The reasons of the conversion were tumor advances for two cases and intra-operative hemorrhage for one case. The severe morbidities and mortalities were observed in 12 LAG cases; one small bowel obstruction, one multiple liver abscess, one cancer incidence of the remnant stomach, one death caused by cancer recurrence, 6 cases of other organ cancer incidences and two death cases of other organ cancer. For OG group, 16 cases were observed; one small bowel obstruction, one cancer in the remnant stomach, one death caused by cancer recurrence, 10 cases of other organ cancer incidences and three death cases of other organ cancer respectively.
(4) conclusions based on the results We could not prove the statistical significances concerning the oncologic safety of the laparoscopic approach to gastric cancers. A follow-up term of at least 5 years is essential for a reliable estimation of recurrent disease, and the number of patients enrolled did not confer enough statistical power for the detection of small group differences in survival.


Session: Poster

Program Number: P314

View Poster

63


  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2025 Society of American Gastrointestinal and Endoscopic Surgeons